Geron Corporation (GERN) financial statements (2021 and earlier)

Company profile

Business Address 919 EAST HILLSDALE BOULEVARD
FOSTER CITY, CA 94404
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments19613916395115114151
Cash and cash equivalents10141116132143
Short-term investments1861261537810293109
Restricted cash and investments0000000
Receivables1110011
Prepaid expense  11111
Other undisclosed current assets21     
Total current assets:20014216696116116153
Noncurrent Assets
Operating lease, right-of-use asset52
Property, plant and equipment1000000
Long-term investments and receivables63201914143319
Long-term investments63201914143319
Other noncurrent assets  1    
Other undisclosed noncurrent assets21     
Total noncurrent assets:71241914143319
TOTAL ASSETS:271166185110130149173
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities301455547
Accounts payable7111001
Accrued liabilities15811112
Employee-related liabilities8533334
Debt 0     
Restructuring reserve     0 
Other undisclosed current liabilities114323235
Total current liabilities:3128878742
Noncurrent Liabilities
Long-term debt and lease obligation292     
Long-term debt, excluding current maturities24      
Operating lease, liability52
Other undisclosed noncurrent liabilities(5)      
Total noncurrent liabilities:292     
Total liabilities:6030878742
Stockholders' equity
Stockholders' equity attributable to parent211135178104122142131
Common stock0000000
Additional paid in capital1,3661,2151,1891,0901,0801,0711,059
Accumulated other comprehensive income (loss)00(0)(0)(0)(0)(0)
Accumulated deficit(1,156)(1,080)(1,011)(986)(958)(928)(928)
Total stockholders' equity:211135178104122142131
TOTAL LIABILITIES AND EQUITY:271166185110130149173

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenue, net  35 
Gross profit:0011636 
Operating expenses(77)(73)(32)(30)(37)(37)(37)
Other undisclosed operating income      1
Operating loss:(77)(73)(31)(29)(31)(1)(36)
Nonoperating income (expense)2(0)(0)(0)(0)(0)(0)
Investment income, nonoperating2      
Other nonoperating income (expense)0(0)(0)(0)(0)(0)(0)
Interest and debt expense(1)      
Loss before gain (loss) on sale of properties:(76)(73)(31)(29)(31)(1)(36)
Other undisclosed net income044    
Net loss:(76)(69)(27)(29)(31)(1)(36)
Other undisclosed net income attributable to parent   1111
Net income (loss) available to common stockholders, diluted:(76)(69)(27)(28)(30)0(36)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss:(76)(69)(27)(29)(31)(1)(36)
Other comprehensive income (loss)(0)00    
Comprehensive loss:(76)(68)(27)(29)(31)(1)(36)
Other undisclosed comprehensive income, net of tax, attributable to parent   1111
Comprehensive loss, net of tax, attributable to parent:(76)(68)(27)(28)(29)(0)(36)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: